TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
APMD

Apnimed, Inc.

Healthcare · Biotechnology

16.60$ -0.9% vs. previous close Closing price · As of: Nov 12, 2026

Ownership

Ownership Structure

Who owns Apnimed, Inc. (APMD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 52.1% of the shares are freely tradable; institutional investors hold 18.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 18.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 37.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 52.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 42Mio.

Largest Shareholders

Funds

Funds APMD
Name Stake (%) Shares Change (%) Date
Columbia Seligman Tech & Info A 17.88 7,443,633 +3.4 09/30/2026
PGIM Jennison Health Sciences Z 1.34 559,263 +14.4 09/30/2026
JPMorgan Small Cap Growth A 1.19 495,265 +0.0 09/30/2026
Highland Global Allocation A 0.97 405,378 +0.0 09/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 0.96 398,486 +544.9 09/30/2026
iShares Russell 2000 ETF 0.76 314,514 +0.0 10/30/2026
AB Small Cap Growth A 0.70 290,871 -2.8 09/30/2026
abrdn Healthcare Opportunities 0.57 238,815 +36.6 09/30/2026
abrdn Healthcare Investors 0.54 224,841 +0.0 09/30/2026
Biotech Growth Ord 0.50 208,000 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?